Viromed Medical AG Working Capital to Net Assets Ratio
Viromed Medical AG working capital to net assets ratio. Viromed Medical AG (Q11) has a Working Capital to Net Assets ratio of 12.7% as of September 2025. Working capital of €34.32 Million (current assets of €95.91 Million minus current liabilities of €61.59 Million) is measured against net assets of €269.20 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Q11 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Viromed Medical AG (2021–2024)
Working capital to net assets ratio of Viromed Medical AG from 2021 to 2024. This chart shows how Viromed Medical AG's Working Capital to Net Assets ratio has evolved across 4 annual periods from 2021 to 2024. As of September 2025, the ratio stands at 12.7%, reflecting working capital of €34.32 Million against net assets of €269.20 Million EUR. See defensive interval ratio of Viromed Medical AG to measure how many days the company can operate on defensive assets alone.
Viromed Medical AG Working Capital to Net Assets Ratio by Year (2021–2024)
Viromed Medical AG working capital to net assets ratio by year from 2021 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Viromed Medical AG from 2021 to 2024, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see how large is Viromed Medical AG's balance sheet.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 9.4% | €18.90 Million | €201.16 Million | €65.88 Million | €46.97 Million | ▲ +12.0 pp |
| 2023 | -2.6% | €-1.65 Million | €64.28 Million | €40.73 Million | €42.38 Million | ▼ -80.8 pp |
| 2022 | 78.2% | €49.47 Million | €63.23 Million | €50.68 Million | €1.21 Million | ▲ +14.3 pp |
| 2021 | 63.9% | €25.54 Million | €39.97 Million | €27.64 Million | €2.10 Million | — |